Rafferty Asset Management
CTIC

Rafferty Asset Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Rafferty Asset Management’s Portfolio CTIC Stock Details CTIC Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
2023
Q1 		$4.77M Sell
2022
Q4 		$8.84M Buy
2022
Q3 		$6.36M Buy
2022
Q2 		$2.61M Buy